PULMATRIX, INC. Fair Value Adjustment of Warrants
PULMATRIX, INC. (PULM) reported Fair Value Adjustment of Warrants of -$67.00 thousand for the 12-month period ending 2025-12-31, per its S-4/A filed 2026-09-17.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2026-09-17
- PULMATRIX, INC. fair value adjustment of warrants for the quarter ending 2025-12-31 was $0.00.
- PULMATRIX, INC. fair value adjustment of warrants for the quarter ending 2025-09-30 was $0.00.
- PULMATRIX, INC. fair value adjustment of warrants for the quarter ending 2025-06-30 was -$1.00K.
- PULMATRIX, INC. fair value adjustment of warrants for the quarter ending 2025-03-31 was -$66.00K.
- PULMATRIX, INC. fair value adjustment of warrants for fiscal 2015 was -$1.31M.
- PULMATRIX, INC. fair value adjustment of warrants for fiscal 2014 was -$211.00K.
| Period end | Fair Value Adjustment of Warrants | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 12 month |
|---|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: S-4/A 12 month − 10-Q 9 month · filed 2026-09-17 | $0.00 derived: sum of 2 quarters · filed 2026-09-17 | -$1.00K derived: sum of 3 quarters · filed 2026-09-17 | -$67.00K S-4/A · filed 2026-09-17 | |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − S-4/A 6 month · filed 2025-10-16 | -$1.00K derived: sum of 2 quarters · filed 2026-09-17 | -$67.00K 10-Q · filed 2025-10-16 | ||
| 2025-06-30 | -$1.00K S-4/A · filed 2026-09-17 | -$67.00K S-4/A · filed 2026-09-17 | |||
| 2025-03-31 | -$66.00K S-4/A · filed 2026-08-03 | ||||
| 2024-12-31 | $67.00K S-4/A · filed 2026-09-17 | ||||
| 2024-11-13 | $0.00 10-K · filed 2025-03-21 | ||||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-10 | $0.00 derived: sum of 2 quarters · filed 2017-03-10 | -$582.00K derived: sum of 3 quarters · filed 2017-03-10 | -$1.31M 10-K · filed 2017-03-10 | |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | -$582.00K derived: sum of 2 quarters · filed 2016-11-04 | -$1.31M 10-Q · filed 2016-11-04 | -$900.00K derived: sum of 4 quarters · filed 2016-11-04 | |
| 2015-06-30 | -$582.00K 10-Q · filed 2016-08-04 | -$1.31M 10-Q · filed 2016-08-04 | -$900.00K derived: sum of 3 quarters · filed 2016-08-04 | -$245.00K derived: sum of 4 quarters · filed 2016-08-04 | |
| 2015-03-31 | -$727.00K 10-Q · filed 2016-05-05 | -$318.00K derived: sum of 2 quarters · filed 2016-05-05 | $337.00K derived: sum of 3 quarters · filed 2016-05-05 | -$786.00K derived: sum of 4 quarters · filed 2016-05-05 | |
| 2014-12-31 | $409.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10 | $1.06M derived: sum of 2 quarters · filed 2016-03-10 | -$59.00K derived: sum of 3 quarters · filed 2016-03-10 | -$211.00K 10-K · filed 2016-03-10 | |
| 2014-09-30 | $655.00K 10-Q · filed 2015-11-12 | -$468.00K derived: sum of 2 quarters · filed 2015-11-12 | -$620.00K 10-Q · filed 2015-11-12 | ||
| 2014-06-30 | -$1.12M 10-Q · filed 2015-08-14 | -$1.27M 10-Q · filed 2015-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |